Department of Health written question – answered at on 6 April 2017.
Lord Alton of Liverpool
Crossbench
To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 28 March (HL6261), whether the Expert Working Group on Hormonal Pregnancy Tests will review the reasons why tests on Primodos, which remained on the market until 1978 despite the publication of a study in 1967 indicating a causal relationship between hormonal pregnancy tests and congenital abnormalities, were not ordered by the Committee for the Safety of Medicines under the Medicines Act 1971.
Lord O'Shaughnessy
The Parliamentary Under-Secretary of State for Health, Lord in Waiting (HM Household) (Whip)
The terms of reference of the Expert Working Group on Hormonal Pregnancy Tests are focused on a scientific review of the strength of evidence for a possible association between exposure in pregnancy to hormonal pregnancy tests and adverse outcomes in pregnancy. An important part of the Group’s work is to consider what lessons may be learnt for further improving existing regulatory systems to identify, monitor and minimise any adverse effects of medicines in pregnancy.
Records show that the Committee on Safety of Drugs (subsequently the Committee on Safety of Medicines) carefully considered the results of the 1967 study and considered the methodology to be flawed.
In 1969, the Committee on Safety of Drugs requested the manufacturers of hormonal pregnancy tests to provide all relevant laboratory data and initiated their own long-term study of maternal drug histories in mothers of children with birth defects. In 1970, the Standing Committee on the Classification of Proprietary Medicines (the ‘MacGregor Committee’) asked Schering, the then licence holder, to remove ‘diagnosis of pregnancy’ from the indications for Primodos.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
In a normal session there are up to ten standing committees on bills. Each has a chair and from 16 to 50 members. Standing committee members on bills are appointed afresh for each new bill by the Committee of Selection which is required to take account of the composition of the House of Commons (ie. party proportions) as well as the qualification of members to be nominated. The committees are chaired by a member of the Chairmen's Panel (whose members are appointed by the Speaker). In standing committees the Chairman has much the same function as the Speaker in the House of Commons. Like the Speaker, a chairman votes only in the event of a tie, and then usually in accordance with precedent. The committees consider each bill clause by clause and may make amendments. There are no standing committees in the House of Lords.
